| 000 | 01670 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518073439.0 | ||
| 264 | 0 | _c20201005 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1865-8652 | ||
| 024 | 7 |
_a10.1007/s12325-019-01156-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChowdhury, Simon | |
| 245 | 0 | 0 |
_aMatching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer. _h[electronic resource] |
| 260 |
_bAdvances in therapy _c01 2020 |
||
| 300 |
_a501-511 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis | ||
| 650 | 0 | 4 |
_aAndrogen Receptor Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aBayes Theorem |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 |
_aPhenylthiohydantoin _xanalogs & derivatives |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aProstatic Neoplasms, Castration-Resistant _xdrug therapy |
| 650 | 0 | 4 |
_aThiohydantoins _xtherapeutic use |
| 700 | 1 | _aOudard, Stéphane | |
| 700 | 1 | _aUemura, Hiroji | |
| 700 | 1 | _aJoniau, Steven | |
| 700 | 1 | _aPilon, Dominic | |
| 700 | 1 | _aLadouceur, Martin | |
| 700 | 1 | _aBehl, Ajay S | |
| 700 | 1 | _aLiu, Jinan | |
| 700 | 1 | _aDearden, Lindsay | |
| 700 | 1 | _aSermon, Jan | |
| 700 | 1 | _aVan Sanden, Suzy | |
| 700 | 1 | _aDiels, Joris | |
| 700 | 1 | _aHadaschik, Boris A | |
| 773 | 0 |
_tAdvances in therapy _gvol. 37 _gno. 1 _gp. 501-511 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12325-019-01156-5 _zAvailable from publisher's website |
| 999 |
_c30397053 _d30397053 |
||